← All diseases
Liver, kidneys and digestion
Fatty liver disease (MASH/NASH), advanced
Do you want to receive a message when there is new research about Liver Fat (MASH/NASH), advanced? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on Liver Steatosis (MASH/NASH), Advanced is available. View what Premium costs.
Publications and studies (2538)
- Non-absorbable antibiotics worsen alcohol-associated liver disease in gastric acid-suppressed mice. (2026/12/31) ♡
- Lonicerin from Dachaihu decoction ameliorates liver steatosis and fibrosis in MASH by inhibiting LY6D. (2026/12/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Multi-target protective effects of Agrimonia pilosa Ledeb. against metabolic dysfunction-associated steatohepatitis in mice. (2026/12/01) ♡
- Huanglian wendan decoction attenuates hepatic inflammation and lipogenesis via inhibition of the NF-κB/HDAC1/SREBP-1c axis. (2026/11/15) ♡
- Targeting autophagy and UPR in NAFLD-induced renal injury: The role of Chlorella vulgaris and Lactobacillus casei. (2026/11/01) ♡
- Combination of Cornus officinalis Siebold and Moutan officinalis (L.) Lindl. alleviates the metabolic disorders of MAFLD through regulating IRE1α/ASK1/JNK pathway mediated endoplasmic reticulum stress. (2026/10/28) ♡
- Systematic characterization of active components and therapeutic mechanisms of Chaihu Guizhi Ganjiang Decoction in metabolic dysfunction-associated steatohepatitis. (2026/10/15) ♡
- Compound Dancao Granules inhibits lipid accumulation and hepatocyte apoptosis via the p53 signaling pathway in metabolic dysfunction-associated steatohepatitis mice. (2026/09/15) ♡
- Qinggan Jiangzhi Cha ameliorates NAFLD by modulating the AGE-RAGE/PRKCA/MAPK3/AP-1 signaling axis. (2026/09/15) ♡
- Mechanism of Jianpi Qinghua granule in ameliorating metabolic dysfunction-associated fatty liver disease by targeting the DNMT-urea cycle axis. (2026/09/15) ♡
- Design, synthesis, and characterization of species-independent h/mGPR35 agonists for MAFLD/MASH. (2026/09/15) ♡
- Arsenic promotes nonalcoholic steatohepatitis via MCFD2-induced PERK/eIF2α-mediated integrated stress response. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Three Dimensional Biomimetic Liver Models to Reconstitute Metabolic Dysfunction-Associated Steatohepatitis (MASH) In Vitro: Hope and Reality. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autophagy in MASLD: A Metabolic and Precision Medicine Perspective. (2026/09/01) ♡
- Gene-Based Clustering Identifies QSOX1 and IL1RAP as Biomarkers of Metabolic Dysfunction-Associated Steatotic Liver Disease. (2026/09/01) ♡
- Steatosis in Cirrhosis: A Prognostic Marker for Liver-Related Outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease. (2026/09/01) ♡
- Shugan Xiaozhi decoction protects mice against metabolic dysfunction associated steatohepatitis by modulating liver injury and intestinal flora. (2026/09/01) ♡
- Integrating UHPLC-Q-TOF/MS and multi-omics to elucidate the regulatory mechanisms of Xiong's Shiwei Wendan decoction in MASLD. (2026/09/01) ♡
- Qi Wei Zhi Gan formulation alleviates progressive fibrosis in metabolic dysfunction-associated steatohepatitis through suppressing Peroxidasin-collagen IV crosslinking. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Stable Isotope-Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets. (2026/09/01) ♡
- Combination therapy in metabolic dysfunction-associated steatohepatitis. (2026/09/01) ♡
- Time-Varying Impact of Steatosis and Alcohol on Mortality: A Marginal Structural Model of the Canadian Longitudinal Study on Aging. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Protective effects of Astragaloside IV on various liver diseases: From chemistry to herbal medicines (Review). (2026/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Identification of anti-fibrotic components of Bofutsushosan under conditions of age-associated obesity in mice. (2026/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Heyehui attenuates diet-induced obesity via regulating LEP/AMPK/ACC axis and restoring intestinal function in mice. (2026/09/01) ♡
- Noncoding RNA Transcripts Based Molecular Phenotyping of MASLD and MASH Patients. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Digital Pathology-Enabled Artificial Intelligence for Fibrosis Assessment in Metabolic Dysfunction-Associated Steatohepatitis: Needs, Current Progress, and Barriers. (2026/09/01) ♡
- Zfp217 Regulates Hepatic de Novo Lipogenesis via METTL3-Mediated N6-Methyladenosine Modification of SREBF1. (2026/08/15) ♡
- CD38 Inhibition Enhances FXR Signaling in Male Rats With Diabetic Steatohepatitis Through SIRT1-Dependent Suppression of NLRP3. (2026/08/15) ♡
- Thermally driven self-assembly of triterpenoid-fructan supramolecular particles contributes significantly to the efficacy of Zexie Tang against MASH. (2026/08/15) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Attrition in Digital Self-Management Interventions for Patients With Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): Mixed Methods Systematic Review. (2026/08/10) ♡
- GDF15 suppresses liver inflammation independently of weight loss through neuroendocrine glucocorticoid signaling. (2026/08/10) ♡
- Hemerocallis lilioasphodelus root water extract ameliorates non-alcoholic fatty liver disease by regulating the gut-liver axis and activating AMPK-mediated lipid metabolism: an integrated study based on metabolomics and 16S rRNA sequencing. (2026/08/10) ♡
- Hyperpolarized γ-Glutamyl-[1-(13)C]Glycine MRI Detects Liver Injury Non-Invasively. (2026/08/10) ♡
- Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study. (2026/08/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Implications of Lipoprotein(a) in MASLD. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epidemiological and socio-economic burden of MASH (previously known as NASH) in Europe: a systematic literature review. (2026/08/08) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Corrigendum to "Trichosanthis Pericarpium injection ameliorates non-alcoholic fatty liver disease via inhibiting the KLF6/ABCC5 pathway in mice" [Phytomedicine. 2025 Sep;145:156998]. (2026/08/08) ♡
- TRIM29-dependent AKR1B10 degradation ameliorates MASH. (2026/08/07) ♡
- miR149-5p: A hepatocyte EXOmotif sequence containing microRNA that attenuates liver fibrosis by specifically targeting PDGFRB in HSCs. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Effects of phytosterols supplementation on hepatic lipid metabolism and metabolic outcomes in obese rodent models: A systematic review and meta-analysis. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The dynamic spectrum of steatotic liver disease: the global perspective. (2026/08/07) ♡
- Liver, Portal, and Systemic Thyroid Hormone Concentrations in End-Stage MASH Reveal Distinct Roles for T3/rT3 Ratio and T4. (2026/08/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Early-life 6:2 diPAP exposure induces SQSTM1/p62-associated NAFLD-like liver injury in juvenile zebrafish. (2026/08/06) ♡
- Cordycepin Alleviates Non Alcoholic Fatty Liver Disease Progression by Stabilizing GCH1 to Inhibit Ferroptosis. (2026/08/06) ♡
- Impact of Obeticholic Acid Therapy on Insulin Resistance and Metabolic Parameters in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Acromegaly and Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical and Therapeutic Implications. (2026/08/05) ♡
- Metabolic Dysfunction-Associated Steatohepatitis Comorbidity Burden and Overall, Waiting-List, and Post-Liver Transplant Mortality. (2026/08/05) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Intrahepatic Klebsiella pneumoniae is associated with host cellular dysfunction in metabolic dysfunction-associated steatohepatitis. (2026/08/04) ♡
- S100A11 regulates hepatic cholesterol metabolism and promotes steatohepatitis via non-canonical SREBP2 signaling. (2026/08/04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.